AFP and hepatocellular carcinoma: Although AFP is often recommended as a serum marker for the surveillance of HCC, the use of AFP to screen a population with chronic liver disease who is at risk of developing HCC has been reported to have a poor sensitivity of only 20 to 30% at cutoff values > 100 ng/mL [42].